How to Invest in HDFC Pharma And Healthcare Fund Direct Growth?

You can easily invest in HDFC Pharma And Healthcare Fund Direct Growth in a hassle-free manner on Groww. The process is extremely simple, quick and completely paperless. Invest in a few minutes with the following steps: Log on to your Groww account Search for HDFC Pharma And Healthcare Fund Direct Growth from the search box In order to invest, you will have to complete all the KYC formalities which are completely online and paperless and take a few minutes to complete Once you are done with that, you can start investing in HDFC Pharma And Healthcare Fund Direct Growth as SIP or lumpsum as per your investment objective and risk tolerance

What kind of returns does HDFC Pharma And Healthcare Fund Direct Growth provide?

The HDFC Pharma And Healthcare Fund Direct Growth has been there from 04 Oct 2023 and the average annual returns provided by this fund is 7.15% since its inception.

How much expense ratio is charged by HDFC Pharma And Healthcare Fund Direct Growth?

The term Expense Ratio used for HDFC Pharma And Healthcare Fund Direct Growth or any other mutual fund is the annual charges one needs to pay to the Mutual Fund company for managing your investments in that fund. The Expense Ratio of HDFC Pharma And Healthcare Fund Direct Growth is 0.94% as of 18 Jan 2026...

What is the AUM of HDFC Pharma And Healthcare Fund Direct Growth?

The AUM, short for Assets Under Management of HDFC Pharma And Healthcare Fund Direct Growth is ₹1,983.91Cr as of 18 Jan 2026.

How to Redeem HDFC Pharma And Healthcare Fund Direct Growth?

If you want to sell your HDFC Pharma And Healthcare Fund Direct Growth holdings, go to your holding on the app or web and simply click on it. You will get two options - redeem & invest more; click on redeem and enter your desired amount or if you wish to redeem the entire holding amount then select the 'redeem all' checkbox.

Can I invest in SIP and Lump Sum of HDFC Pharma And Healthcare Fund Direct Growth?

You can select either SIP or Lumpsum investment of HDFC Pharma And Healthcare Fund Direct Growth based on your investment objective and risk tolerance.

What is the NAV of HDFC Pharma And Healthcare Fund Direct Growth?

The NAV of HDFC Pharma And Healthcare Fund Direct Growth is ₹17.52 as of 16 Jan 2026.

What is the PE and PB ratio of HDFC Pharma And Healthcare Fund Direct Growth?

The PE ratio ratio of HDFC Pharma And Healthcare Fund Direct Growth is determined by dividing the market price by its earnings per share and the PB ratio of the same is evaluated by dividing the stock price per share by its book value per share (BVPS).

Stocks

Invest in Stocks

Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.

Intraday

Monitor top intraday performers in real time

ETF Screener

Get the best of Mutual Funds and flexibility of Stocks

IPO

Track upcoming and ongoing IPOs

MTFs

Buy now, pay later

Stock Screener

Filter based on RSI, PE ratio and more

Stock Events

Dividends, bonus, buybacks and more

Demat Account

Begin your stock market journey

Share Market Today

Live news updates from stock market

F&O

Trade in Futures & Options

Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space

Indices

Track markets across the globe

Terminal

Track charts, orders, positions, watchlists in one place

Option chain

Analyse chains, view payoffs, create baskets

Pledge

Get extra balance for trading

Commodities

Trade in Crude Oil, Gold, Silver and more

API trading

Set up and execute trades through our API

Mutual Funds

Invest in Mutual Funds

Invest in direct mutual funds at zero charges via lump sump investments or SIPs

Mutual Fund Houses

Know about AMCs, funds, fund managers

NFO’s

Track all active NFOs in one place

Mutual Funds by Groww

Mutual funds by Groww designed for your investment goals

Start SIP

Build long-term wealth through disciplined monthly investing.

Mutual Funds screener

Filter funds based on risk, fund size and more

Track Funds

Import funds and track all investments in a single place

Compare Funds

SIP calculator

Estimate returns on a SIP

Brokerage calculator

Estimate charges for your trade/investment

Margin calculator

Estimate balance needed to buy/sell a stock

SWP calculator

Returns on your systematic withdrawal plan

Pricing

Brokerage and charges on Groww

Blog

HDFC Pharma And Healthcare Fund Direct Growth

Name: HDFC Pharma And Healthcare Fund Direct Growth
Brand: HDFC Mutual Fund

Equity

Sectoral

Very High Risk

All

NAV: 16 Jan '26

₹17.52

Min. SIP amount

₹100

Fund size

₹1,983.91 Cr

Expense ratio

0.94%

Return calculator

Monthly SIP

One time

Monthly investment

₹5,000

Over the past	Total investment	Would've become	Historic returns	Returns
1 year	₹60,000	₹62,175		+3.62%

Holdings (30)

Name	Sector	Instruments	Assets
Sun Pharmaceutical Industries Ltd.	Healthcare	Equity	10.79%
Divi's Laboratories Ltd.	Healthcare	Equity	8.35%
Glenmark Pharmaceuticals Ltd.	Healthcare	Equity	6.45%
Lupin Ltd.	Healthcare	Equity	6.04%
Alkem Laboratories Ltd.	Healthcare	Equity	5.78%
Max Healthcare Institute Ltd.	Healthcare	Equity	5.74%
Ipca Laboratories Ltd.	Healthcare	Equity	4.56%
Anthem Biosciences Ltd.	Healthcare	Equity	4.05%
Torrent Pharmaceuticals Ltd.	Healthcare	Equity	3.89%
Aster DM Healthcare Ltd.	Healthcare	Equity	3.34%
Laurus Labs Ltd.	Healthcare	Equity	3.29%
Krishna Institute of Medical Sciences Ltd	Healthcare	Equity	3.02%
Acutaas Chemicals Ltd.	Healthcare	Equity	2.91%
Cipla Ltd.	Healthcare	Equity	2.89%
Fortis Healthcare Ltd.	Healthcare	Equity	2.83%
Eris Lifesciences Ltd.	Healthcare	Equity	2.59%
Metropolis Healthcare Ltd.	Healthcare	Equity	2.50%
Vijaya Diagnostic Centre Ltd.	Healthcare	Equity	2.48%
Wockhardt Ltd.	Healthcare	Equity	1.88%
Dr. Lal Pathlabs Ltd.	Healthcare	Equity	1.76%
Jubilant Pharmova Ltd.	Healthcare	Equity	1.72%
Sai Life Sciences Ltd.	Healthcare	Equity	1.69%
Thyrocare Technologies Ltd.	Healthcare	Equity	1.62%
Shilpa Medicare Ltd.	Healthcare	Equity	1.32%
Global Health Ltd.	Healthcare	Equity	1.16%
Bajaj Healthcare Ltd.	Healthcare	Equity	1.10%
Gland Pharma Ltd.	Healthcare	Equity	1.09%
Rubicon Research Ltd.	Healthcare	Equity	1.09%
CORONA Remedies Ltd.	Healthcare	Equity	0.99%
Laxmi Dental Ltd.	Healthcare	Equity	0.88%

See All

Minimum investments

Min. for 1st investment

₹100

Min. for 2nd investment

₹100

Min. for SIP

₹100

Returns and rankings

Annualised returns

Absolute returns

Name	3M	6M	1Y	All
Fund returns	+0.6%	-0.4%	+7.1%	+76.8%
Category average (Equity Sectoral)	--	--	-2.1%	--
Rank (Equity Sectoral)	3	6	1	--

Exit load, stamp duty and tax

Exit load

Exit load of 1%, if redeemed within 30 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Check past data

Fund management

DM
Dhruv Muchhal
Sep 2023 - Present
View details

Education

Mr. Dhruv has done B.Com, CA and CFA

Experience

Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells

Also manages these schemes

HDFC Non Cyclical Consumer Fund Direct Growth

HDFC Medium Term Debt Fund Direct Growth

HDFC Dynamic Debt Fund Direct Plan Growth

HDFC Ultra Short Term Fund Direct Growth

HDFC Income Fund Direct Growth

HDFC Hybrid Equity Fund Direct Plan Growth

HDFC ELSS Tax Saver Fund Direct Plan Growth

HDFC Children's Fund Direct Plan

HDFC Diversified Equity All Cap Active FoF Direct Growth

HDFC Innovation Fund Direct Growth

HDFC Business Cycle Fund Direct Growth

HDFC MNC Fund Direct Growth

HDFC Transportation and Logistics Fund Direct Growth

HDFC Liquid Direct Plan Growth

HDFC Retirement Savings Fund Equity Plan Direct Growth

HDFC Banking & Financial Services Fund Direct Growth

HDFC Money Market Fund Direct Growth

HDFC Equity Savings Direct Plan Growth

HDFC Focused Fund Direct Growth

HDFC Technology Fund Direct Growth

HDFC Banking and PSU Debt Fund Direct Growth

HDFC Value Fund Direct Plan Growth

HDFC Low Duration Fund Direct Growth

HDFC Hybrid Debt Fund Direct Growth

HDFC Overnight Fund Direct Growth

HDFC Pharma And Healthcare Fund Direct Growth

HDFC Credit Risk Debt Fund Direct Growth

HDFC Arbitrage Direct Plan Growth

HDFC Small Cap Fund Direct Growth

HDFC Multi Cap Fund Direct Growth

HDFC Long Duration Debt Fund Direct Growth

HDFC Mid Cap Fund Direct Growth

HDFC Corporate Bond Fund Direct Plan Growth

HDFC Retirement Savings Fund Hybrid Debt Plan Direct Growth

HDFC Retirement Savings Fund Hybrid Equity Plan Direct Growth

HDFC Housing Opportunities Fund Direct Growth

HDFC Infrastructure Fund Direct Growth

HDFC Large and Mid Cap Fund Direct Growth

HDFC Balanced Advantage Fund Direct Growth

HDFC Flexi Cap Direct Plan Growth

HDFC Arbitrage Fund Wholesale Direct Growth

HDFC Large Cap Fund Direct Growth

HDFC Floating Rate Debt Fund Direct Plan Growth

HDFC Short Term Debt Fund Direct Plan Growth

HDFC Manufacturing Fund Direct Growth

HDFC Defence Fund Direct Growth

HDFC Multi Asset Allocation Fund Direct Growth

NM
Nikhil Mathur
Sep 2023 - Present
View details

Education

Mr. Mathur has done B.Tech and PGDM in Finance

Experience

Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY

Also manages these schemes

HDFC Pharma And Healthcare Fund Direct Growth

About HDFC Pharma And Healthcare Fund Direct Growth

HDFC Pharma And Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 10 Dec 1999. Dhruv Muchhal is the Current Fund Manager of HDFC Pharma And Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹9,32,192 Cr and the Latest NAV as of 16 Jan 2026 is ₹17.52. The HDFC Pharma And Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100. Exit load of 1%, if redeemed within 30 days. ;

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Fund benchmarkBSE Healthcare Total Return Index

Scheme Information Document(SID)